nach oben

World Journal of Urology

Erschienen in:

01.10.2013 | Invited Review

Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials

verfasst von: Matthias Oelke, Vik Khullar, Hessel Wijkstra

Erschienen in: World Journal of Urology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To provide a narrative review of literature evaluating ultrasound techniques for the measurement of bladder wall hypertrophy in women as an alternative to invasive urodynamic assessment for the diagnosis of lower urinary tract symptoms (LUTS).

Methods

A literature review was performed using PubMed and all paper journals of congress abstracts searching for articles on ultrasound measurement of bladder wall thickness (BWT) or detrusor wall thickness (DWT) published between January 1990 and May 2012. Each study was classified with a level of evidence using the Oxford Centre for Evidence-based Medicine classification (2009).

Results

Ultrasound measurement of bladder wall hypertrophy is not standardised, and techniques vary widely according to anatomical approach, ultrasound frequency and other factors. This review compared transvaginal, translabial/transperineal and suprapubic approaches for ultrasound BWT/DWT measurement. BWT/DWT measurements correlated well with urodynamic diagnoses of detrusor overactivity (DO) using all three ultrasound techniques. BWT values were consistently higher in women with DO than in women with stress incontinence, although threshold values for the differential diagnosis of DO varied between clinical studies (5.0–6.5 mm using transvaginal ultrasound). Few data were available on the use of translabial or suprapubic ultrasound in women. Inter- and intraobserver variability was higher with transperineal and suprapubic ultrasound, and these techniques appear less reliable than transvaginal ultrasound. Studies suggest that BWT is reduced in response to antimuscarinic therapy in women with overactive bladder or DO.

Conclusions

Data from clinical trials suggest that transvaginal ultrasound measurement of BWT is a reliable method of diagnosing DO in women with LUTS, and BWT decreases during antimuscarinic therapy.

Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29:4–20PubMed

Ashok K, Wang A (2010) Detrusor overactivity: an overview. Arch Gynecol Obstet 282:33–41PubMedCrossRef

Siegel SW, Richardson DA, Miller KL, Karram MM, Blackwood NB, Sand PK, Staskin DR, Tuttle JP (1997) Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women. Urology 50:934–940PubMedCrossRef

Antunes-Lopes T, Carvalho-Barros S, Cruz CD, Cruz F, Martins-Silva C (2011) Biomarkers in overactive bladder: a new objective and noninvasive tool? Adv Urol. doi:10.1155/2011/382431 PubMed

Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP (1998) Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. J Urol 159:191–194PubMedCrossRef

Porru D, Madeddu G, Campus G, Montisci I, Scarpa RM, Usai E (1999) Evaluation of morbidity of multi-channel pressure-flow studies. Neurourol Urodyn 18:647–652PubMedCrossRef

Anders K, Cardozo L, Ashman O, Khullar V (2002) Morbidity after ambulatory urodynamics. Neurourol Urodyn 21:461–463PubMedCrossRef

Cartwright R, Afshan I, Derpapas A, Vijaya G, Khullar V (2011) Novel biomarkers for overactive bladder. Nat Rev Urol 8:139–145PubMedCrossRef

Levin RM, O’Connor LJ, Leggett RE, Whitbeck C, Chichester P (2003) Focal hypoxia of the obstructed rabbit bladder wall correlates with intermediate decompensation. Neurourol Urodyn 22:156–163PubMedCrossRef

10.

Oelke M (2010) International Consultation on Incontinence-Research Society (ICI-RS) report on non-invasive urodynamics: the need of standardization of ultrasound bladder and detrusor wall thickness measurements to quantify bladder wall hypertrophy. Neurourol Urodyn 29:634–639PubMedCrossRef

11.

Khullar V, Salvatore S, Cardozo L, Bourne TH, Abbott D, Kelleher C (1994) A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound. Ultrasound Obstet Gynecol 4:220–223PubMedCrossRef

12.

Khullar V, Cardozo LD, Salvatore S, Hill S (1996) Ultrasound: a noninvasive screening test for detrusor instability. Br J Obstet Gynaecol 103:904–908PubMedCrossRef

13.

Kuhn A, Bank S, Robinson D, Klimek M, Kuhn P, Raio L (2010) How should bladder wall thickness be measured? A comparison of vaginal, perineal and abdominal ultrasound. Neurourol Urodyn 29:1393–1396PubMedCrossRef

14.

Robinson D, Anders K, Cardozo L, Bidmead J, Toozs-Hobson P, Khullar V (2002) Can ultrasound replace ambulatory urodynamics when investigating women with irritative urinary symptoms? BJOG 109:145–148PubMedCrossRef

15.

Serati M, Salvatore S, Cattoni E, Soligo M, Cromi A, Ghezzi F (2010) Ultrasound measurement of bladder wall thickness in different forms of detrusor overactivity. Int Urogynecol J 21:1405–1411PubMedCrossRef

16.

Kuhn A, Genoud S, Robinson D, Herrmann G, Gunthert A, Brandner S, Raio L (2011) Sonographic transvaginal bladder wall thickness: does the measurement discriminate between urodynamic diagnoses? Neurourol Urodyn 30:325–328PubMedCrossRef

17.

Ibrahim S, Najdy M (2011) Measuring bladder wall thickness in cases of detrusor instability using transvaginal ultrasound. International Continence Society annual meeting, Glasgow, UK (abstract 676)

18.

Parsons M, Vella M, Cardozo L (2005) Does bladder wall thickness discriminate detrusor overactivity from overactive bladder and normality? International Continence Society annual meeting, Montreal, Canada (abstract 383)

19.

Kuo HC (2009) Measurement of detrusor wall thickness in women with overactive bladder by transvaginal and transabdominal sonography. Int Urogynecol J Pelvic Floor Dysfunct 20:1293–1299PubMedCrossRef

20.

Yang JM, Huang WC (2003) Bladder wall thickness on ultrasonographic cystourethrography: affecting factors and their implications. J Ultrasound Med 22:777–782PubMed

21.

Yang J-M, Huang W-C (2002) Discrimination of bladder disorders in female lower urinary tract symptoms on ultrasonographic cystourethrography. J Ultrasound Med 21:1249–1255PubMed

22.

Oswald J, Schwentner C, Lunacek A, Fritsch H, Longato S, Sergi C, Bartsch G, Radmayr C (2006) Reevaluation of the fetal muscle development of the vesical trigone. J Urol 176:1166–1170PubMedCrossRef

23.

Panayi DC, Tekkis P, Fernando R, Hendricken C, Khullar V (2010) Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome. Neurourol Urodyn 29:1295–1298PubMedCrossRef

24.

Otsuki E, Castro R, Sartori MGF, Girao MJBC, Jarmy-Di Bella Z (2010) Is there a difference in bladder wall thickness between continent and women with stress urinary incontinence or overactive bladder? International Urogynecological Association annual meeting, Toronto, Canada (abstract 934)

25.

Panayi D, Khullar V, Fernando R, Hendricken C, Tekkis P (2009) Is ultrasound bladder wall thickness a better objective measure than urodynamics for overactive bladder symptoms? International Continence Society annual meeting, San Francisco, USA (abstract 160)

26.

Lekskulchai O, Dietz HP (2008) Detrusor wall thickness as a test for detrusor overactivity in women. Ultrasound Obstet Gynecol 32:535–539PubMedCrossRef

27.

Lekskulchai O, Dietz HP (2009) Is detrusor hypertrophy in women associated with voiding dysfunction? Aust N Z J Obstet Gynaecol 49:653–656PubMedCrossRef

28.

Minardi D, Piloni V, Amadi A, El Asmar Z, Milanese G, Muzzonigro G (2007) Correlation between urodynamics and perineal ultrasound in female patients with urinary incontinence. Neurourol Urodyn 26:176–182PubMedCrossRef

29.

Oelke M, Hofner K, Wiese B, Grunewald V, Jonas U (2002) Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World J Urol 19:443–452PubMed

30.

Oelke M, Hofner K, Jonas U, de la Rosette JJ, Ubbink DT, Wijkstra H (2007) Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol 52:827–834PubMedCrossRef

31.

Chung SD, Chiu B, Kuo HC, Chuang YC, Wang CC, Guan Z, Chancellor MB (2010) Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder. BJU Int 105:668–672PubMedCrossRef

32.

Kuo HC, Liu HT, Chancellor MB (2010) Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourol Urodyn 29:482–487PubMed

33.

Ozturk H, Aydur E, Irkilata HC, Seckin B, Dayanc M (2011) The diagnostic role of transabdominal ultrasonographic bladder wall thickness in female urinary incontinence. International Continence Society annual meeting, Glasgow, UK (abstract 388)

34.

Blatt AH, Titus J, Chan L (2008) Ultrasound measurement of bladder wall thickness in the assessment of voiding dysfunction. J Urol 179:2275–2279PubMedCrossRef

35.

Panayi DC, Khullar V, Fernando R, Tekkis P (2010) Transvaginal ultrasound measurement of bladder wall thickness: a more reliable approach than transperineal and transabdominal approaches. BJU Int 106:1519–1522PubMedCrossRef

36.

Ke Q-S, Kuo H-C (2011) The promise of bladder wall thickness as a useful biomarker for objective diagnosis of lower urinary tract dysfunction. Tzu Chi Med J 23:1–8CrossRef

37.

Khullar V, Salvatore S, Cardozo L, Hill S (1994) Bladder wall thickness: an objective measure of drug efficacy? Int Urogynecol J 5, 327 (abstract 33)

38.

Khullar V, Hill S, Cardozo L, Amos C, Guan Z (2007) A multi-centre, randomised, placebo-controlled, double-blind, parallel group study to evaluate whether tolterodine extended release can reverse the increased bladder wall thickness in women with overactive bladder. International Continence Society annual meeting, Rotterdam, The Netherlands (abstract 124)

39.

Panayi DC, Tekkis P, Fernando R, Khullar V (2010) Is the beneficial effect of antimuscarinics related to motor or sensory changes in the bladder? Int Urogynecol J 21:841–845PubMedCrossRef

40.

Robinson D, Oelke M, Khullar V, Tretter R, Stow B, Compion G, Tubaro A (2012) Bladder wall thickness in women with symptoms of overactive bladder and detrusor overactivity: baseline data from the SHRINK study. European Association of Urology annual meeting Paris, Late breaking abstract

Titel: Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials
verfasst von: Matthias Oelke
Vik Khullar
Hessel Wijkstra
Publikationsdatum: 01.10.2013
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 5/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-013-1030-6

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2013

Correlation of the RENAL nephrometry score with warm ischemia time after robotic partial nephrectomy

Adrenal tumours are more predominant in females regardless of their histological subtype: a review

Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy

Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database